Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients

Drugs & Aging 2026

View at publisher
Authors: Javier Loricera, J. Molina Collada, Juan Carlos Nieto, Marina Sánchez‐Lucas, María T. Silva-Díaz, Patricia Moya, Eztizen Labrador, Iván Ferraz‐Amaro, Ricardo Blanco
DOI: 10.1007/s40266-026-01281-1
Cited by: 1
References: 33

Fields of Study & Subjects

Vasculitis and related conditions Systemic Sclerosis and Related Diseases Systemic Lupus Erythematosus Research

Publication details

Journal / source
Drugs & Aging
Publisher
Springer Science and Business Media LLC
Volume
43
Issue
3
Pages
277–284
Publication date
19 February 2026
Language
EN